T cell-based segment

IOVA		Iovance Biotherapeutics, Inc. - Common Stock			1.15% down 8.46% -7.31		+ Biotechnology, Gene and cell, Immunology, Cancer fight, Disease: Oncology, T cell-based Last highlighted: #IOVA SEC report: IOVANCE BIOTHERAPEUTICS, INC. Current report, items 2.02 and 9.01 SEC Filing Form 8-K filed by IOVANCE BIOTHERAPEUTICS, INC. -- SEC File Number 211148127	+ My List
ZIOP		ZIOPHARM Oncology Inc - Common Stock			-8.18% -8.18% 0		+ T cell-based, Cancer fight, Disease: Oncology, Immunology, Medicine	+ My List
CNTB		Connect Biopharma Holdings Limited - American Depositary Shares			0		+ Biopharma, Country: China, T cell-based Last highlighted: $CNTB 6-K Connect Biopharma (16 Jun, 4:01pm) 📰 Current report (foreign) https://t.co/U5Q30mPOFH #CNTB #6K #ConnectBiopharma #News	+ My List
LVTX		LAVA Therapeutics N.V. - Ordinary Shares			11.56% up 10.36% 1.2		+ T cell-based, Cancer fight, Medicine, Disease: Oncology	+ My List

We do not provide financial advice. All displayed data is the result of experiments, and a subjective assessment. All decisions that will be made based on this data are made at your own risk. Thank you for understanding.